FDA will release notification rule to curb drug shortages

06/20/2013 | Health Data Management

Drugmakers will have to notify the FDA about interruptions or discontinuances in the manufacturing of life-saving treatments under a proposed rule that the agency is set to publish. The rule would mandate early notification from makers of drugs considered life-sustaining or life-supporting or that are used in the treatment or prevention of debilitating diseases.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC